BE820660A - Procede de detection d'antigenes ou d'anticorps - Google Patents

Procede de detection d'antigenes ou d'anticorps

Info

Publication number
BE820660A
BE820660A BE149173A BE149173A BE820660A BE 820660 A BE820660 A BE 820660A BE 149173 A BE149173 A BE 149173A BE 149173 A BE149173 A BE 149173A BE 820660 A BE820660 A BE 820660A
Authority
BE
Belgium
Prior art keywords
antigen
detection process
antibody detection
antibody
detection
Prior art date
Application number
BE149173A
Other languages
English (en)
Inventor
I Bornstein
A Kapsalis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE820660A publication Critical patent/BE820660A/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/819—Multifunctional antigen or antibody
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Materials By The Use Of Magnetic Means (AREA)
BE149173A 1973-10-26 1974-10-03 Procede de detection d'antigenes ou d'anticorps BE820660A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/410,066 US3949064A (en) 1973-10-26 1973-10-26 Method of detecting antigens or antibodies

Publications (1)

Publication Number Publication Date
BE820660A true BE820660A (fr) 1975-02-03

Family

ID=23623067

Family Applications (1)

Application Number Title Priority Date Filing Date
BE149173A BE820660A (fr) 1973-10-26 1974-10-03 Procede de detection d'antigenes ou d'anticorps

Country Status (15)

Country Link
US (2) US3949064A (fr)
JP (1) JPS5762020B2 (fr)
AU (1) AU476619B2 (fr)
BE (1) BE820660A (fr)
BR (1) BR7408886A (fr)
CA (1) CA1036493A (fr)
DE (1) DE2450523C3 (fr)
ES (1) ES431413A1 (fr)
FR (1) FR2249334B1 (fr)
GB (1) GB1436934A (fr)
IL (1) IL45707A (fr)
LU (1) LU71027A1 (fr)
NL (1) NL7413552A (fr)
SE (1) SE7413484L (fr)
ZA (1) ZA746098B (fr)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172117A (en) * 1974-05-20 1979-10-23 Biotest-Serum-Institut Gmbh Method for the simultaneous measurement of antigens and their antibodies by solid-phase radioimmunoassay
US4225784A (en) * 1976-06-17 1980-09-30 Smith Kline Instruments, Inc. Covalently bound biological substances to plastic materials and use in radioassay
AT343822B (de) * 1976-08-20 1978-06-26 Immuno Ag Radioimmunologisches verfahren und einrichtung zur bestimmung von antigenen
JPS604422B2 (ja) * 1976-10-07 1985-02-04 持田製薬株式会社 抗原の定量方法
USRE34394E (en) * 1978-01-23 1993-09-28 Baxter Diagnostics Inc. Method and composition for double receptor, specific binding assays
JPS608745B2 (ja) * 1978-02-14 1985-03-05 三洋化成工業株式会社 免疫活性物質−つや消しガラス複合体，その製造法及び該複合体を含有してなる測定試薬
US4242322A (en) * 1978-06-07 1980-12-30 Electro-Nucleonics Laboratories, Inc. Methods and materials for detecting antigens and antibodies
US4393040A (en) * 1981-03-24 1983-07-12 Lopapa Institute, Inc. In-vitro diagnostic method for detection of acetylsalicylic acid ingestion
US4994373A (en) 1983-01-27 1991-02-19 Enzo Biochem, Inc. Method and structures employing chemically-labelled polynucleotide probes
US5242798A (en) * 1983-07-21 1993-09-07 Scripps Clinic And Research Foundation Synthetic polypeptides corresponding to portions of proteinoids translated from brain-specific mRNAs, receptors, methods and diagnostics using the same
EP0135277B1 (fr) * 1983-07-21 1986-10-29 Scripps Clinic And Research Foundation Polypeptides synthétiques correspondant aux portions de protéinoides traduites de mARNs spécifiques au cerveau, récepteurs, méthode et diagnose utilisant ceux-ci
DE3586772T2 (de) * 1984-07-24 1993-03-04 Coselco Mimotopes Pty Ltd Verfahren zur bestimmung von mimotopen.
US5182082A (en) * 1991-01-23 1993-01-26 Becton, Dickinson And Company Multiple aliquot device for distributing a liquid solution into a well
US5877028A (en) * 1991-05-29 1999-03-02 Smithkline Diagnostics, Inc. Immunochromatographic assay device
US5998220A (en) * 1991-05-29 1999-12-07 Beckman Coulter, Inc. Opposable-element assay devices, kits, and methods employing them
US6168956B1 (en) 1991-05-29 2001-01-02 Beckman Coulter, Inc. Multiple component chromatographic assay device
US5348867A (en) * 1991-11-15 1994-09-20 George Georgiou Expression of proteins on bacterial surface
US5698686A (en) * 1994-10-20 1997-12-16 Arch Development Corporation Yeast telomerase compositions
US5807552A (en) * 1995-08-04 1998-09-15 Board Of Regents, The University Of Texas System Compositions for conferring immunogenicity to a substance and uses thereof
EP0854934A4 (fr) * 1995-08-18 2000-09-06 Donald W Landry Detection de composes organiques par regulation de reactions catalysees par des anticorps
US6689757B1 (en) 1996-02-12 2004-02-10 M.L. Laboratories Plc Methods for vaccination and vaccines therefor
US20020034732A1 (en) * 1997-07-30 2002-03-21 Daniel J. Capon Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US6610838B1 (en) 1997-09-10 2003-08-26 Symbicom Aktiebolag P13 antigens from Borrelia
HK1044040A1 (zh) 1998-11-16 2002-10-04 德克萨斯州立大学董事会 Hiv-特异的t-细胞诱导
WO2002036777A1 (fr) * 2000-11-02 2002-05-10 The National University Of Singapore Gene aopb, proteine, homologues, fragments et variants de celui-ci, ainsi que l'utilisation de ces derniers pour presentation a la surface cellulaire
US7847084B2 (en) 2002-12-20 2010-12-07 Board Of Regents, The University Of Texas System VMP-like sequences of pathogenic Borrelia species and strains
WO2005035556A2 (fr) * 2003-05-06 2005-04-21 Iguazu Biosciences Corp. Particules pseudo-virales du coronavirus du sras et methodes d'utilisation
CA2526690C (fr) 2003-05-23 2014-01-14 Board Of Regents The University Of Texas System Oligonucleoside phosphorothioate selectionnes de maniere combinatoire et a base structurelle et facteurs de transcription ap-1 ciblant un phosphorodithioate aptamere
EP1998800A2 (fr) 2006-01-18 2008-12-10 University Of Chicago Compositions et procédés se rapportant à des protéines de bactéries staphylococciques
NZ578657A (en) * 2007-02-02 2012-02-24 Baylor Res Inst Multivariable antigens complexed with targeting humanized monoclonal antibody
TWI422594B (zh) 2007-02-02 2014-01-11 Baylor Res Inst 經由樹狀細胞去唾液酸糖蛋白受體（ｄｃ-ａｓｇｐｒ）接合抗原呈現細胞之藥劑
MX2009008140A (es) 2007-02-02 2009-10-26 Baylor Res Inst Vacunas a base de antigeno dirigido a dcir expresado en celulas que presentan antigeno.
CN101679949B (zh) 2007-02-23 2015-08-19 贝勒研究院 通过dectin-1激活人抗原呈递细胞的治疗性应用
CA2717656A1 (fr) * 2007-02-23 2008-08-28 Baylor Research Institute Activation de cellules humaines presentant un antigene par l'intermediaire de clec-6
EP2132226B1 (fr) 2007-02-23 2019-03-27 Baylor Research Institute Activation de cellules humaines presentant un antigene par l'intermediaire du recepteur ldl 1 oxyde de type lectine (lox-1) de cellules dendritiques
WO2009059328A2 (fr) * 2007-11-02 2009-05-07 The Johns Hopkins University Vaccin l2 multicomposant pour la prévention d'une infection de papillomavirus humain
KR20110036618A (ko) 2008-07-16 2011-04-07 베일러 리서치 인스티튜트 극대화된 Ｇａｇ 및 Ｎｅｆ를 수지상 세포에 표적화시킴을 기본으로 하는 ＨＩＶ 백신
WO2010042481A1 (fr) 2008-10-06 2010-04-15 University Of Chicago Compositions et procédés associés aux protéines bactériennes eap, emp, et/ou adsa
EP3281947B1 (fr) 2009-04-03 2020-02-12 The University of Chicago Compositions et procédés liés aux variantes de la protéine a (spa)
WO2011100508A2 (fr) 2010-02-12 2011-08-18 Arizona Board Of Regents For And On Behalf Of Arizona State University Procédés et compositions liés à des fusions glycoprotéine-immunoglobuline
EP2555794A4 (fr) 2010-04-05 2014-01-15 Univ Chicago COMPOSITIONS ET PROCÉDÉS LIÉS AUX ANTICORPS DE LA PROTÉINE A (SpA) EN TANT QUE AMPLIFICATEUR DE LA RÉPONSE IMMUNITAIRE
ES2655701T3 (es) 2010-07-02 2018-02-21 The University Of Chicago Composiciones y métodos relacionados con variantes de la proteína A (SpA)
JP5793194B2 (ja) 2010-09-09 2015-10-14 ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ 感染防御ブドウ球菌抗原が関与する方法および組成物
WO2012058635A1 (fr) 2010-10-29 2012-05-03 Life Technologies Corporation Dérivés de biotine
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
HRP20201127T1 (hr) 2012-04-26 2020-11-27 University Of Chicago Antigeni stafilokokne koagulaze i metode primjene istih
US9701719B2 (en) 2012-09-27 2017-07-11 Research Development Foundation Attenuated Chikungunya virus
US10358667B2 (en) 2013-03-07 2019-07-23 University Of Maryland, Baltimore Immunotherapeutic potential of modified lipooligosaccharides/lipid A
JP6836500B2 (ja) 2014-05-16 2021-03-03 ベイラー リサーチ インスティテュートＢａｙｌｏｒ Ｒｅｓｅａｒｃｈ Ｉｎｓｔｉｔｕｔｅ 自己免疫状態および炎症状態を治療するための方法および組成物
US10662226B2 (en) 2016-10-28 2020-05-26 The Regents of the University of Caiifomia Synthetic beta-amyloid peptides capable of forming stable antigenic oligomers
WO2019183500A1 (fr) 2018-03-23 2019-09-26 Hung Chiung Yu Antigènes de coccidioides et leurs procédés d'utilisation
WO2020041360A1 (fr) 2018-08-21 2020-02-27 Quidel Corporation Anticorps dbpa et leurs utilisations
EP3947454A1 (fr) 2019-03-27 2022-02-09 INSERM (Institut National de la Santé et de la Recherche Médicale) Protéines recombinantes ayant des propriétés d'activation de cd40
AU2020273471B2 (en) 2019-05-14 2026-05-07 The University Of Chicago Methods and compositions comprising Staphylococcus protein A (SpA) variants
JP2023502712A (ja) 2019-11-21 2023-01-25 インサーム（インスティテュ ナシオナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシェ メディカル） 抗ｐｄ－１／ｉｌ－１５免疫サイトカインによる新しいｐｄ－１標的免疫療法
WO2021178637A1 (fr) 2020-03-05 2021-09-10 Iowa State University Research Foundation, Inc. Compositions immunogènes et vaccinales dirigées contre le sars-cov-2
US20230183366A1 (en) 2020-05-13 2023-06-15 Inserm (Institut National De La Santé Et De La Recherch Médicale) Recombinant proteins with ox40 activating properties
WO2023144779A1 (fr) 2022-01-28 2023-08-03 Pfizer Inc. Variants d'antigène de coronavirus
WO2025017036A1 (fr) 2023-07-17 2025-01-23 Institut National de la Santé et de la Recherche Médicale Échafaudages tubulaires hélicoïdaux alfavirus nsp3
WO2025027492A1 (fr) 2023-07-31 2025-02-06 Pfizer Inc. Variants d'antigène de coronavirus
WO2025257397A1 (fr) 2024-06-14 2025-12-18 Institut National de la Santé et de la Recherche Médicale Vaccins vivants atténués de bordetella capables de produire et de sécréter des antigènes hétérologues
WO2026022374A1 (fr) 2024-07-26 2026-01-29 Institut National de la Santé et de la Recherche Médicale Méthodes de traitement prophylactique d'infections par le virus chikungunya

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE337223B (fr) * 1967-05-23 1971-08-02 Pharmacia Ab
SE343210B (fr) * 1967-12-20 1972-03-06 Pharmacia Ab
US3646346A (en) * 1968-12-26 1972-02-29 Pharmacia Ab Antibody-coated tube system for radioimmunoassay
US3867517A (en) * 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies

Also Published As

Publication number Publication date
IL45707A0 (en) 1974-11-29
DE2450523C3 (de) 1978-06-22
USRE29955E (en) 1979-04-03
SE7413484L (fr) 1975-04-28
DE2450523B2 (de) 1976-10-07
AU476619B2 (en) 1976-09-30
DE2450523A1 (de) 1975-05-22
IL45707A (en) 1977-01-31
LU71027A1 (fr) 1975-04-17
US3949064A (en) 1976-04-06
NL7413552A (nl) 1975-04-29
ES431413A1 (es) 1976-10-16
JPS5762020B2 (fr) 1982-12-27
BR7408886A (pt) 1976-05-04
JPS5075095A (fr) 1975-06-20
FR2249334A1 (fr) 1975-05-23
FR2249334B1 (fr) 1977-03-25
ZA746098B (en) 1975-11-26
CA1036493A (fr) 1978-08-15
GB1436934A (en) 1976-05-26
AU7378774A (en) 1976-04-01

Similar Documents

Publication Publication Date Title
FR2274047A1 (fr) Nouveau procede de detection de la presence d'antigenes et d'anticorps
BR7408886A (pt) Processo para a detectacao da presenca de proteinas com acao de antigenos ou anticorpos
BE799417A (fr) Procede de direction et de determination d'haptenes,
BE795950A (fr) Procede de preparation d'amidosilanes
BE807706A (fr) Procede pour la preparation de cycloalcanones et/ou cycloalcanols
IT1006706B (it) Sistema multielaboratore
BE786518A (fr) Procede de preparation d'oxa-bicyclo-alcenes
CH550757A (fr) Procede de preparation d'acides cyclopropylmethylphenylacetiques.
FR2277891A1 (fr) Methode pour deceler par radio-immunometrie la presence d'anticorps de la blennorragie
CH554319A (fr) Procede de preparation d'aryl-guanidines ortho-disubstituees.
CH551437A (fr) Procede de preparation d'acides chromone-carboxyliques.
BE797732A (fr) Procede de preparation d'oximes
FR2290848A1 (fr) Procede d'isolement de proteines
BE817761A (fr) Procede de preparation d'o-benzyltoluenes
BE831145A (fr) Procede de dosage immunologique utilisant un systeme heterologue d'anticorps ou d'antigenes
BE795902A (fr) Procede de preparation du diiodo-3,5 hydroxy-4benzonitrile et de l'iodo-3 hydroxy-4 nitro-5benzonitrile
BE802306A (fr) Procede de preparation d'agregats
BE774540A (fr) Procede de preparation de l'omega laurinolactame
BE809499A (fr) Procede et reactif pour le dosage de la creatinekinase
BE787014A (fr) Procede et reactif pour deceler la presence de l'antigene australien
BE811703A (fr) Procede de preparation d'isocyanato-triazines
BE807087A (fr) Procede pour la preparation de thiazolines-(3)
RO62297A (fr) Procede de obtention d'un mixture proteique
BE799405A (fr) Procede pour la purification d'antigene carcinoembryonnaire
BE781275A (fr) Procede de preparation d'o-aminobenzonitriles